Danapha- professional entry to science and technology
Danapha Pharmaceutical Joint Stock Company (Danapha) was established in 1965 as Vietnam Central Region Pharmaceutical Factory with the primary mission of providing pharmaceuticals in fields ranging from disease prevention to treatment for Vietnamese people and soldiers. For over 50 years, Danapha has been constantly adding exceptional values through the development and manufacture of valuable pharmaceutical products for the benefit of human health in Vietnam. Our core competency is tremendous effort in applying and placing science, technology, and innovation at the center of our development process. Danapha today has reached to top of the best pharmaceutical companies in Vietnam and continued to bring our new scientific and technological pharmaceuticals to international market.
 

Danapha's factory were standardized to meet GMP regulations

 

One of our growth strategies was initiated from creating technology platforms. Danapha’s factories and facilities were standardized to meet stringent Good Manufacturing Practice (GMP) regulations complying with the World Health Organization’s international norms. Our state-of-the art factories are located on pollution free zones, which are approximately 10 km from the city center. We opened an independent and modern herbal medicine production line in order to develop our own directory of medicinal materials used in quality check and create traditional herbal products in innovative formulas. Through positive investments on technology, Danapha has the capacity of producing high quality medicines such as Bai Thach, Tadimax, Vg5, and so on. It is positive that all of these products launched has received high appreciation from experts and patients.   
 

Our insights in Nanotechnology
Ten years ago, when Nanotechnology was a new and emerging technology in Pharmacy, Danapha has put our serious efforts in researching and developing many projects related to this promising field. We highly evaluate the potential of Nanotechnology to create new generations of novel pharmaceuticals and radically change human health care. A new subsidiary company named Danosome has been founded with the aim of underpinning Nanotechnology development. In 2009, Danapha invested over 20 billion VND to develop a modern R&D Center. We pride ourselves on offering many important Nanotechnology- applied products in Vietnam such as Gasmin, Moflex, Silysom, Nanogold, and so on. Liposome Paclitaxel is one of the most advanced nanotechnology pharmaceuticals in Vietnam, effectively treating ovary cancer and metastatic breast cancers. In 2016, Danapha was awarded the Certification of Science and Technology enterprise and the license to invest and develop our research and manufacture in Danang Hi-tech Park (The project’s value of 1.500 Billion VND)  

 

 

Looking ahead, Danapha will take on new challenges to expand our market and advance even more powerfully with our growth strategies in science and technology. We also keep developing an identity as a proactive company bringing efficacy and differentiable products, delivering significant pharmaceutical benefits for the community, and enhancing human health in Vietnam and in the world.